97 Results

People

  1. Rampal
    Rampal
  2. Levine
    Levine
  3. Abdel-Wahab
    Abdel-Wahab
  4. Perales
    Perales
  5. Giralt
    Giralt
  6. Berger
    Berger
  7. Devlin
    Devlin
  8. Dogan
    Dogan
  9. Rapaport
    Rapaport
  10. Xiao
    Xiao

Groups

  1. Center for Hematologic Malignancies (76)
  2. Department of Medicine (76)
  3. Hematologic Malignancies, Division of (74)
  4. Adult Leukemia (54)
  5. GSK Faculty (42)
  6. Executive Committee, Center for Hematologic Malignancies (36)
  7. Human Oncology and Pathogenesis Program (28)
  8. Tow Center for Developmental Oncology (TCDO) (22)
  9. Center for Molecular Imaging and Biotechnology (16)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (15)
  1. "myeloproliferative neoplasm"
Formats
  1. Journal Article (77)
  2. Review (13)
  3. Research Letter (6)
  4. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (76)
  2. Department of Medicine (76)
  3. Hematologic Malignancies, Division of (74)
  4. Adult Leukemia (54)
  5. GSK Faculty (42)
  6. Executive Committee, Center for Hematologic Malignancies (36)

More Groups

People
  1. Raajit Rampal (29)
  2. Ross Levine (25)
  3. Omar Abdel-Wahab (14)
  4. Miguel-Angel Perales (7)
  5. Sergio Giralt (6)
  6. Ahmet Dogan (5)

More People

Years
  1. 2025 (10)
  2. 2024 (15)
  3. 2023 (7)
  4. 2022 (7)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Blood (10)
  2. Leukemia (7)
  3. Blood Advances (6)
  4. Haematologica (6)
  5. Current Hematologic Malignancy Reports (3)
  6. Hematology/Oncology Clinics of North America (3)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Nature Publishing Group (13)
  3. Elsevier Inc. (11)
  4. Springer (7)
  5. Ferrata Storti Foundation (6)
  6. Wiley Blackwell (6)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimization of allogeneic hematopoietic cell transplantation for patients with myelofibrosis treated with ruxolitinib: Eligibility, best practices, and improving transplant outcomes
    Review

    Wall, S. A.; Tamari, R.; DeFilipp, Z.; Hobbs, G. S.
    Annals of Hematology (2025)

    Fulltext@MSK | Save
  • Assessing AML-based risk criteria in patients with accelerated/blastphase MPN treated with less-intensive therapy
    Research Letter

    Shaw, R.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A. J.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Reducing clinical trial eligibility barriers for patients with MDS: An icMDS position statement
    Review

    Borate, U.; Pugh, K.; Waller, A.; Welkie, R. L.; Huang, Y.; Bewersdorf, J. P.; Stahl, M.; DeZern, A. E.; Platzbecker, U.; Sekeres, M. A.; more...
    Hematology-American Society of Hematology Education Program (2025)

    Fulltext@MSK | Save
  • Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia
    Review

    Patel, A. A.; Rampal, R. K.
    Haematologica (2025)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Health-related values discussions with patients undergoing allogeneic and autologous stem cell transplant: Feasibility and acceptability of an early primary palliative care intervention
    Journal Article

    Cohen, A. G.; Cho, C.; Patterson, E.; Magaldi, J.; Doga, T.; Naputo, K.; Alvarez, K.; Giles, E.; Yang, G.; Hoque, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Preclinical efficacy of CDK7 inhibitor–based combinations against myeloproliferative neoplasms transformed to AML
    Journal Article

    Fiskus, W.; Mill, C. P.; Bose, P.; Masarova, L.; Pemmaraju, N.; Dunbar, A.; Birdwell, C. E.; Davis, J. A.; Das, K.; Hou, H.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety
    Review

    Masarova, L.; Mascarenhas, J.; Rampal, R.; Hu, W.; Livingston, R. A.; Pemmaraju, N.
    Cancer (2025)

    Fulltext@MSK | Save
  • Basophilia predicts poorer outcomes in essential thrombocythemia, polycythemia vera, primary myelofibrosis, and myeloproliferative neoplasm, unclassifiable
    Research Letter

    Yuen, L.; Gogakos, T.; Boiocchi, L.; Hobbs, G.; Hasserjian, R.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Impact of recent translational and therapeutic developments on clinical course of BCR::ABL1-positive and -negative myeloproliferative neoplasms
    Review

    Mughal, T. I.; Mascarenhas, J.; Rampal, R. K.; Bose, P.; Lion, T.; Ajufo, H.; Yacoub, A.; Meshinchi, S.; Masarova, L.; Mesa, R.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save